Document Detail

Treatment of idiopathic sclerosing inflammation of the orbit (myositis) with infliximab.
MedLine Citation:
PMID:  18631325     Owner:  NLM     Status:  MEDLINE    
PURPOSE: We report the successful use of infliximab in a young patient with idiopathic sclerosing orbital inflammation (myositis). METHODS: We describe the patient's medical records and review the literature. RESULTS: Idiopathic myositis in this patient could not be satisfactorily treated with corticosteroids or chemotherapy. Biopsy showed sclerosing orbital inflammation. The patient had a prompt and sustained response with infliximab and methotrexate treatment. CONCLUSIONS: Infliximab and methotrexate might be considered in patients with idiopathic sclerosing orbital inflammation (myositis).
Sven Sahlin; B?rje Lignell; Maria Williams; Maryam Dastmalchi; Abiel Orrego
Related Documents :
25491675 - Demographic and comorbidity profile of patients with lower urinary tract symptoms sugge...
23239865 - Scalp reconstruction using dermal induction template: state of the art and personal exp...
22581125 - Improved outcomes in paediatric anaesthesia: contributing factors.
6264365 - Thygeson's superficial punctate keratitis.
759635 - Early observations on 31 adults with non-refluxing colon conduits.
3677765 - Transbronchial biopsy during mechanical ventilation.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Acta ophthalmologica     Volume:  87     ISSN:  1755-3768     ISO Abbreviation:  Acta Ophthalmol     Publication Date:  2009 Nov 
Date Detail:
Created Date:  2009-12-16     Completed Date:  2010-02-26     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101468102     Medline TA:  Acta Ophthalmol     Country:  England    
Other Details:
Languages:  eng     Pagination:  906-8     Citation Subset:  IM    
St Erik's Eye Hospital, Karolinska Institute, Stockholm, Sweden.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Adrenal Cortex Hormones / therapeutic use
Antibodies, Monoclonal / therapeutic use*
Drug Therapy, Combination
Magnetic Resonance Imaging
Methotrexate / therapeutic use*
Orbital Myositis / diagnosis,  drug therapy*,  pathology*
Treatment Failure
Reg. No./Substance:
0/Adrenal Cortex Hormones; 0/Antibodies, Monoclonal; 0/infliximab; 59-05-2/Methotrexate

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The role of behavioral impulsivity in the development of alcohol dependence: a 4-year follow-up stud...
Next Document:  Macular microcirculation in hypertensive patients with and without branch retinal vein occlusion.